Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: Role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation

Experimental Cell Research

Volumn 316, Issue 1, 2010, Pages 38-47

  Brugnoli, Federica ^a   Lambertini, Elisabetta ^b   Varin Blank, Nadine ^c,d   Piva, Roberta ^b   Marchisio, Marco ^e   Grassilli, Silvia ^a   Miscia, Sebastiano ^e   Capitani, Silvano ^a,b   Bertagnolo, Valeria ^a  

^a Signal Transduction Unit   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c INSERM   (France)

^d UNIVERSITÉ PARIS 13   (France)

^e UNIVERSITY OF CHIETI   (Italy)

Author keywords

ATRA; CD11b; Differentiation; NB4; PU.1; Vav1

Indexed keywords

CD11B ANTIGEN; PROTEIN VAV1; REGULATOR PROTEIN; RETINOIC ACID; TRANSCRIPTION FACTOR PU 1; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA PROTEIN COMPLEX; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; PROMOTER REGION; PROMYELOCYTE; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

EID: 70449715126     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.09.004     Document Type: Article

References (33)

1. Lo-Coco F., and Ammatuna E. The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment. Hematology 2006 (2006) 156-161
2. Tallman M. Treatment of relapsed or refractory acute promyelocytic leukemia. Best Pract. Res. Cl. Ha. 20 (2007) 57-65
3. Breitman T.R., Selonick S.E., and Collins S.J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 2936-2940
4. Lanotte M., Martin-Thouvenin V., Najman S., Balerini P., Valensi F., and Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77 (1991) 1080-1086
5. Yang L., Zhao H., Li S.-W., Ahrens K., Collins C., Eckenrode S., Ruan Q.G., McIndoe R.A., and She J.X. Gene expression profiling during all-trans retinoic acid-induced cell differentiation of acute promyelocytic leukemia cells. J. Mol. Diagn. 5 (2003) 212-221
6. Mistry A.R., Pedersen E.W., Solomon E., and Grimwade D. The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease. Blood 17 (2003) 71-97
7. Kastner P., and Chan S. PU.1: a crucial and versatile player in hematopoiesis and leukemia. Int. J. Biochem. Cell Biol. 40 (2008) 22-27
8. Mueller B.U., Pabst T., Fos J., Petkovic V., Fey M.F., Asou N., Buergi U., and Tenen D.G. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood 107 (2006) 3330-3338
9. Durual S., Rideau A., Ruault-Jungblut S., Cossali D., Beris P., Piguet V., and Matthes T. Lentiviral PU.1 overexpression restores differentiation in myeloid leukemic blasts. Leukemia 21 (2007) 1050-1059
10. Pahl H.L., Scheibe R.J., Zhang D.E., Chen H.M., Galson D.L., Maki R.A., and Tenen D.G. The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J. Biol. Chem. 268 (1993) 5014-5020
11. Barber N., Belov L., and Christopherson R.I. All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias. Leuk. Res. 32 (2007) 315-322
12. Rice A.M., Holtz K.M., Karp J., Rollins S., and Sartorelli A.C. Analysis of the relationship between Scl transcription factor complex protein expression patterns and the effects of LiCl on ATRA-induced differentiation in blast cells from patients with acute myeloid leukemia. Leuk. Res. 28 (2004) 1227-1237
13. Katzav S. Flesh and blood: the story of Vav1, a gene that signals in hematopoietic cells but can be transforming in human malignancies. Cancer Lett. 255 (2007) 241-254
14. Bertagnolo V., Brugnoli F., Mischiati C., Sereni A., Bavelloni A., Carini C., and Capitani S. Vav promotes differentiation of human tumoral myeloid precursors. Exp. Cell Res. 306 (2005) 56-63
15. Katzav S. Vav1: an oncogene that regulates specific transcriptional activation of T cells. Blood 103 (2004) 2443-2451
16. Bustelo X.R. Regulation of Vav proteins by intramolecular events. Front. Biosci. 7 (2002) 24-30
17. Katzav S. Vav1: A hematopoietic signal transduction molecule involved in human malignancies. Int. J. Biochem. Cell Biol. 41 (2008) 1245-1248
18. Tybulewicz V.L. Vav-family proteins in T-cell signaling. Curr. Opin. Immunol. 17 (2005) 267-274
19. Houlard M., Arudchandran R., Regnier-Ricard F., Germani A., Gisselbrecht S., Blank U., Rivera J., and Varin-Blank N. Vav1 is a component of transcriptionally active complexes. J. Exp. Med. 195 (2002) 1115-1127
20. Schneider H., and Rudd C.E. CD28 and Grb-2, relative to Gads or Grap, preferentially co-operate with Vav1 in the activation of NFAT/AP-1 transcription. Biochem. Biophys. Res. Com. 369 (2008) 616-621
21. Piccolella E., Spadaro F., Ramoni C., Marinari B., Costanzo A., Levrero M., Thomson L., Abraham R.T., and Tuosto L. Vav-1 and the IKK alpha subunit of I kappa B kinase functionally associate to induce NF-kappa B activation in response to CD28 engagement. J. Immunol. 170 (2003) 2895-2903
22. Zhang R., Tsai F.Y., and Orkin S.H. Hematopoietic development of vav- /- mouse embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 12755-12759
23. Bertagnolo V., Grassilli S., Bavelloni A., Brugnoli F., Piazzi M., Candiano G., Petretto A., Benedusi M., and Capitani S. Vav1 modulates protein expression during ATRA-induced maturation of APL-derived promyelocytes: a proteomic-based analysis. J. Proteome Res. 7 (2008) 3729-3736
24. Bertagnolo V., Marchisio M., Volinia S., Caramelli E., and Capitani S. Nuclear association of tyrosine-phosphorylated Vav to phospholipase C-gamma1 and phosphoinositide 3-kinase during granulocytic differentiation of HL-60 cells. FEBS Lett. 441 (1998) 480-484
25. Lambertini E., Tavanti E., Torreggiani E., Penolazzi L., Gambari R., and Piva R. ERalpha and AP-1 interact in vivo with a specific sequence of the F promoter of the human ERalpha gene in osteoblasts. J. Cell. Physiol. 216 (2008) 101-110
26. Bertagnolo V., Marchisio M., Brugnoli F., Bavelloni A., Boccafogli L., Colamussi M.L., and Capitani S. Requirement of tyrosine-phosphorylated Vav for morphological differentiation of all trans-retinoic acid-treated HL-60 cells. Cell Growth Differ. 12 (2001) 193-200
27. Bertagnolo V., Brugnoli F., Marchisio M., Celeghini C., Carini C., and Capitani S. Association of PI3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells. Cell. Signal. 16 (2004) 423-433
28. Seow C.J., Chue S.C., and Wong W.S. Piceatannol, a Syk-selective tyrosine kinase inhibitor, attenuated antigen challenge of guinea pig airways in vitro. Eur. J. Pharmacol. 443 (2002) 189-196
29. Bertagnolo V., Marchisio M., Pierpaoli S., Colamussi M.L., Brugnoli F., Visani G., Zauli G., and Capitani S. Selective up-regulation of phospholipase C-beta2 during granulocytic differentiation of normal and leukemic hematopoietic progenitors. J. Leukoc. Biol. 71 (2002) 957-965
30. Brugnoli F., Bovolenta M., Benedusi M., Miscia S., Capitani S., and Bertagnolo V. PLC-beta2 monitors the drug-induced release of differentiation blockade in tumoral myeloid precursors. J. Cell. Biochem. 98 (2006) 160-173
31. Brugnoli F., Bavelloni A., Benedusi M., Capitani S., and Bertagnolo V. PLC-beta2 activity on actin-associated polyphosphoinositides promotes migration of differentiating tumoral myeloid precursors. Cell. Signal. 19 (2007) 1701-1712
32. Rosmarin A.G., Levy R., and Tenen D.G. Cloning and analysis of the CD18 promoter. Blood 79 (1992) 2598-2604
33. Denkinger D.J., Lambrecht T.Q., Cushman-Vokoun A.M., and Kawahara R.S. PU.1 regulates the expression of the vav proto-oncogene. J. Cell. Biochem. 84 (2002) 772-783